Teva Pharmaceutical Industries reported $2.04B in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 61.85M 18.11M
ALKERMES ALKS:US $ 310.44M 52.1M
Amarin AMRN:US $ 222.88M 104.14M
Amgen AMGN:US $ 11969M 5339M
AstraZeneca AZN:LN 7067M 8500M
Biogen BIIB:US $ 1541.8M 200.2M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Coherus Biosciences CHRS:US $ 360.54M 30.8M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Emergent Biosolutions EBS:US $ 403.8M 43.7M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
Flexion Therapeutics FLXN:US $ 136.82M 29.2M
Gilead Sciences GILD:US $ 6837M 1944M
GlaxoSmithKline GSK:LN 3453M 50M
Henry Schein HSIC:US $ 119.13M 48.1M
Horizon Pharma HZNP:US $ 1068.55M 256.23M
Jazz Pharmaceuticals JAZZ:US 1000 0
Lannett LCI:US $ 105.32M 12.04M
Novartis NOVN:VX SF 7211M 2094M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Patterson Companies PDCO:US $ 154.15M 17.22M
Perrigo Ordinary Shares PRGO:US $ 2078.1M 1760.6M
Phibro Animal Health PAHC:US $ 41.18M 9.04M
Revance Therapeutics RVNC:US $ 127.18M 40.46M
Supernus Pharmaceuticals SUPN:US $ 215.28M 8.49M
Takeda 4502:JP Y 607881M 47039M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
Xeris Pharmaceuticals Inc XERS:US $ 59.49M 4.11M
Zoetis ZTS:US $ 3272M 385M